Evidence map›Paper›PMID 29350646›Full record

ReviewActa bio-medica : Atenei Parmensis2018

Radiofrequency ablation of osteoid osteoma.

Massimo De Filippo, Umberto Russo, Vito Roberto Papapietro, Francesco Ceccarelli, Francesco Pogliacomi, Enrico Vaienti, Claudia Piccolo, Raffaella Capasso, Assunta Sica, Fabrizio Cioce and 4 more

Abstract readReview
In one paragraph

Review in Acta bio-medica : Atenei Parmensis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Musculoskeletal Intervention in Children: An Update.Cardiovascular and interventional radiology · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Massimo De Filippo. umberto.russo1@studenti.unipr.it.
Umberto Russo
Vito Roberto Papapietro
Francesco Ceccarelli
Francesco Pogliacomi
Enrico Vaienti
Claudia Piccolo
Raffaella Capasso
Assunta Sica
Fabrizio Cioce
Mattia Carbone
Federico Bruno
Carlo Masciocchi
Vittorio Miele

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoid osteoma is a benign bone neoplasm with a reported incidence of 2-3% among all bone primary tumors. Although it is a small and benign lesion, it is often cause of patient complaint and discomfort. It is generally characterized by a long lasting, unremitting pain that typically exacerbates at night, often leading to sleep deprivation and functional limitation of the skeletal segment involved, with a significant reduction of patient daily life activities and consequent worsening of the overall quality of life. Over decades, complete surgical resection has represented the only curative treatment for symptomatic patients. In the last years, new percutaneous ablation techniques, especially radiofrequency ablation, have been reported to be a safe and effective alternative to classical surgery, with a low complication and recurrence rate, and a significant reduction in hospitalization cost and duration. The aim of this article is to provide an overview about the radiofrequency thermal ablation procedure in the treatment of osteoid osteoma.

Indexed as

Bone NeoplasmsHumansImaging, Three-DimensionalMagnetic Resonance Imaging, InterventionalOsteoma, OsteoidRadiofrequency AblationRadiography, InterventionalInterventional radiology, Osteoid Osteoma, Bone tumors, Radiofrequency ablation

Identifiers

PMID29350646
PMCPMC6179079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.